EGR1 c.493_494delinsCT ;(p.T165L)

Variant ID: 5-137802631-AC-CT

NM_001964.2(EGR1):c.493_494delinsCT;(p.T165L)

This variant was identified in 2 publications

View GRCh38 version.




Publications:


Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration.

Ebiomedicine
Rhee, Soo-Yon SY; Varghese, Vici V; Holmes, Susan P SP; Van Zyl, Gert U GU; Steegen, Kim K; Boyd, Mark A MA; Cooper, David A DA; Nsanzimana, Sabin S; Saravanan, Shanmugam S; Charpentier, Charlotte C; de Oliveira, Tulio T; Etiebet, Mary-Ann A MA; Garcia, Federico F; Goedhals, Dominique D; Gomes, Perpetua P; Günthard, Huldrych F HF; Hamers, Raph L RL; Hoffmann, Christopher J CJ; Hunt, Gillian G; Jiamsakul, Awachana A; Kaleebu, Pontiano P; Kanki, Phyllis P; Kantor, Rami R; Kerschberger, Bernhard B; Marconi, Vincent C VC; D'amour Ndahimana, Jean J; Ndembi, Nicaise N; Ngo-Giang-Huong, Nicole N; Rokx, Casper C; Santoro, Maria M MM; Schapiro, Jonathan M JM; Schmidt, Daniel D; Seu, Lillian L; Sigaloff, Kim C E KCE; Sirivichayakul, Sunee S; Skhosana, Lindiwe L; Sunpath, Henry H; Tang, Michele M; Yang, Chunfu C; Carmona, Sergio S; Gupta, Ravindra K RK; Shafer, Robert W RW
Publication Date: 2017-04

Variant appearance in text: 225: T165L
PubMed Link: 28365230
Variant Present in the following documents:
  • Main text
View BVdb publication page



Nonpolymorphic human immunodeficiency virus type 1 protease and reverse transcriptase treatment-selected mutations.

Antimicrobial Agents And Chemotherapy
Shahriar, Rajin R; Rhee, Soo-Yon SY; Liu, Tommy F TF; Fessel, W Jeffrey WJ; Scarsella, Anthony A; Towner, William W; Holmes, Susan P SP; Zolopa, Andrew R AR; Shafer, Robert W RW
Publication Date: 2009-11

Variant appearance in text: 225: T165L
PubMed Link: 19721070
Variant Present in the following documents:
  • Main text
View BVdb publication page